C-rad -B (CRAD-B.ST) traded down -4.55 % during a 24 hours period ending at 06:35 PM Central Europe on Monday 26th. One C-rad -B stock can currently be bought for about SEK 21.1 on popular exchanges. Current supply of C-rad -B stocks is 33.8 mn. C-rad -B has a current market capitalization of SEK 709.1 mn and approximately SEK 5.9 mn worth of C-rad -B was traded on exchanges in the last 24 hours. Since last month end, C-rad -B has traded -38.24 % down. Simple moving average of last 200 days is at SEK 32.05. The highest price of past 52 weeks was recorded at SEK 39.4 on 06/25/2026. 52 weeks low was at SEK 18.85 on 10/22/2026.

Here is how related stocks have performed in the past 24 hours:

  • Profiln -B (PROF-B.ST) traded down -1.75 % and now trades at SEK 112.5. Current market capitalisation for Profiln -B is SEK 832.4 mn. Current price/earnings ratio for Profiln -B is 5.66.

  • Dicot Pharma (DICOT.ST) traded up 1.41 % and now trades at SEK 0.23. Current market capitalisation for Dicot Pharma is SEK 747.9 mn.

  • Studentbostader I Norden (STUDBO.ST) traded up 0.42 % and now trades at SEK 1.16. Studentbostader I Norden has a market capitalisation of SEK 829.1 mn.

  • Aac Clyde Space (AAC.ST) traded up 5.59 % and now trades at SEK 99.9. Current market capitalisation for Aac Clyde Space is SEK 794.4 mn.

  • Net Insight (NETI-B.ST) traded down -1.2 % and now trades at SEK 2.49. Net Insight has a market capitalisation of SEK 844.1 mn.

About C-rad -B

C-RAD AB is a health care equipment and supplies company that specializes in developing, manufacturing, and selling systems with applications in radiation therapy for the treatment of cancer globally. The company operates through two segments, Positioning and Imaging, and has its main focus on providing innovative solutions for better patient positioning and resource management within radiation therapy. Their product range includes optical surface scanning systems, surface image guided radiation therapy solutions, 4D SIGRT solutions, advanced particle therapy solutions, enhanced positioning solutions for tomotherapy, laser positioning products, and an X-ray detector optimized for electronic portal imaging devices in radiation therapy. C-RAD AB offers installation, application training, and aftersales services, and has partnership agreement with XECAN to develop products to advance patient positioning and resource management within radiation therapy. The company was founded in 2004 and is headquartered in Uppsala, Sweden.